Calidi Biotherapeutics
CLDI | AMEX
$0.59
-$0.03 (-5.13%)
At close: Nov 16, 2026, 3:59 PM ET
$0.58
-$0.01 (-0.85%)
After-hours:
Nov 16, 2026, 5:13 PM ET
-5.13%
(1D)No price chart data available for 1D timeframe.
Rating
33.8
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #685/1021 (Top 67%)
Key Statistics
Market Data
Market Cap $2.15M
1D Range
0.59 0.65
52W Range
0.59 24.64
Valuation (TTM)
PE -0.03
PB 1.32
EV/EBITDA 0.05
Valuation (NTM)
Forward PE N/A
Forward PEG 0.00
Price Target $5.50
Cash Flow
FCF Yield -737.1%
SBC Adj. FCF Yield -778.9%
SBC Impact -5.7%
Margins
Gross Margin 0.0%
Operating Margin 0.0%
FCF Margin N/A
Growth (CAGR)
Revenue 3Y | 5Y N/A |
-100.0%
Dil EPS 3Y | 5Y 130.5% |
48.3%
FCF 3Y | 5Y 5.4% |
3.4%
Returns
ROA -289.1%
ROE -474.7%
ROIC -644.9%
Financial Health
Net Cash
$3.09M
Current Ratio 1.27
Interest Coverage -112.82
Dividends
Div Yield 62.71%
Payout Ratio -10.6%
FCF Payout Ratio N/A
Loading financial charts...
Profile
Calidi Biotherapeutics, Inc. is a clinical-stage biotechnology company focused on immuno-oncology, dedicated to developing advanced immunotherapies for various cancers. The company's innovative approa...
Sector Healthcare
Industry Biotechnology
Employees 29
IPO Date Nov 1, 2021
Website calidibio.com
Fiscal Year January - December
Latest News
No news articles available yet.
Add to Watchlist
Select watchlists to add or remove CLDI